SC 13G: EUPRAXIA PHARMACEUTICALS INC.
Ticker: EPRX · Form: SC 13G · Filed: Nov 14, 2024 · CIK: 1581178
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by EUPRAXIA PHARMACEUTICALS INC..
Risk Assessment
Risk Level: low
Filing Stats: 884 words · 4 min read · ~3 pages · Grade level 15.5 · Accepted 2024-11-14 16:17:44
Filing Documents
- b81067919.htm (SC 13G) — 46KB
- image0.jpg (GRAPHIC) — 1KB
- 0000899140-24-001257.txt ( ) — 49KB
(a)
Item 1(a) Name of Issuer : Eupraxia Pharmaceuticals Inc.
(b)
Item 1(b) Address of Issuer's Principal Executive Offices : 201-2067 Cadboro Bay Road, Victoria, British Columbia, Canada V8R 5GR. Items 2(a) Name of Person Filing : This Schedule 13G is being filed by Robert Disbrow (the "Reporting Person").
(b)
Item 2(b) Address of Principal Business Office : The business address of the Reporting Person is: 200 Burrard Street, Suite 700 Vancouver, BC V6C 3L6
(c)
Item 2(c) Citizenship : Robert Disbrow is a citizen of Canada.
(d)
Item 2(d) Title of Class of Securities : Common shares, with no par value ("Common Shares")
(e)
Item 2(e) CUSIP Number : 29842P105 Item 3 If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is : (a) Broker or dealer registered under Section 15 of the Act (b) Bank as defined in Section 3(a)(6) of the Act (c) Insurance company as defined in Section 3(a)(19) of the Act (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E) (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F) (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G) (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813) (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (j) A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J) (k) Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). Item 4 The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for each Select Reporting Person and is incorporated herein by reference for each such Select Reporting Person. Item 5 If this statement is being filed to report the fact that as of the date hereof a reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following . Item 6 N/A Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company : N/A Item 8 Identification and Classification of Members of the Group : N/A Item 9 Notice of Dissolution of Group : N/A Item 10 Certification : N/A
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: November 14, 2024 /s/ Robert Disbrow Robert Disbrow